Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1Jordi Esteve, Marı́a Rozman, José‐Tomás Navarro et al.|Annals of Hematology|2014Cited by 29
Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterationsHartmut Döhner, Andrew H. Wei, Ana Alfonso Piérola et al.|Blood|2025Cited by 10
Phase 1b study of bleximenib in combination with venetoclax in Acute Myeloid Leukemia with KMT2A or NPM1 alterationsJenny O’Nions, Sylvain Garciaz, Andrew H. Wei et al.|Blood|2025Cited by 4